![Erythromycin EP Impurity H;Erythromycin N-Oxide ; Erythromycin Ethyl Succinate EP Impurity H ; 2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyl-tetrahydropyran-4-amine oxide | 992-65-4](https://drjcrbio.com/wp-content/uploads/e-9.png)
Erythromycin EP Impurity H;Erythromycin N-Oxide ; Erythromycin Ethyl Succinate EP Impurity H ; 2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyl-tetrahydropyran-4-amine oxide | 992-65-4
Description
| Code: JCERM-09 |
| CAS: 992-65-4 |
| Chemical Formula: C37H67NO14 |
| Molecular Weight: 749.93 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Erythromycin EP Impurity H;Erythromycin N-Oxide ; Erythromycin Ethyl Succinate EP Impurity H ; 2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyl-tetrahydropyran-4-amine oxide | 992-65-4 is useful as reference Impurity standard. |
